[Experimental study on the apoptotic effect of arsenic trioxide on human osteosarcoma MG-63 cells]

Tao Xiao1, Kang-hua Li, Jian-zhen Fang

  • 1Department of Othopaedics, Xiangya Hospital, Central South University, Changsha 410008, China.

Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|February 11, 2003
PubMed
Abstract

Insights

Arsenic trioxide (As2 O3) effectively induces apoptosis in human osteosarcoma MG-63 cells. This study observed characteristic cellular changes, confirming As2 O3 as a potential agent for osteosarcoma treatment.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Osteosarcoma is a primary malignant bone tumor.
  • Developing effective therapeutic agents for osteosarcoma is crucial.

Purpose of the Study:

  • To investigate the apoptotic effects of arsenic trioxide (As2 O3) on human osteosarcoma MG-63 cells.

Main Methods:

  • MTT reduction assay to assess cell viability.
  • Transmission electron microscopy (TEM) for ultrastructural analysis.
  • Agarose gel electrophoresis to detect DNA fragmentation.

Main Results:

  • As2 O3 treatment induced typical apoptotic morphological changes in MG-63 cells.
  • TEM revealed nucleolus disappearance and chromatin condensation.
  • Agarose gel electrophoresis showed DNA laddering, indicative of apoptosis.

Conclusions:

  • Arsenic trioxide (As2 O3) demonstrates a significant capacity to induce apoptosis in human osteosarcoma MG-63 cells.
  • Further research into the precise mechanisms of As2 O3-induced apoptosis is warranted.

Related Concept Videos